Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 30, Amgen Inc.

A newly developed two-step ex vitro transformation method has significantly improved the efficiency and speed of generating ...

Researchers at DTU Biosustain (The Novo Nordisk Foundation Center for Biosustainability at DTU) have developed a new tool ...

Policy on additional costs All students should normally be able to complete their programme of study without incurring additional study costs over and above the tuition fee for that programme. Any ...

UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson's disease, in its Phase 1 study ...

Centuries before biotechnology had a name, humans were already practicing it – breeding animals for resilience, fermenting foods and treating pain with plants. Today, that same spirit of discovery ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced 24-week post-end of treatment data from Part B of the ongoing MARCH Phase 2 clinical study evaluating t ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced 24-week post-end of treatment data from Part B of the ongoing MARCH Phase 2 clinical study evaluating tobevibart and elebsiran without or with ...

At one point, Unity Biotechnology was valued at $700 million, according to a Forbes report in 2018. The company went public in May 2018. Unity Biotechnology is located at 285 E Grand Ave. in South ...

The commission’s findings and recommendations reminded Lee of the 2020 study Safeguarding the Bioeconomy, a study he was part of for the National Academies of Sciences, Engineering and Medicine. That ...

Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Liver (EASL) Congress 2025 Provided by Business Wire Apr 24 ...

UBX1325-treated patients saw a mean BCVA gain of +5.5 ETDRS letters at 36 weeks. Unity plans to release full 36-week data for all patients in Q2 2025. Get ahead of Wall Street reactions—Benzinga ...